Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing
Qibin Liao(Shanghai Public Health Clinical Center), Jianqing Xu(Weifang Medical University)
Cited by 40
Related Papers
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection
|Proceedings of the National Academy of Sciences|2013|287
Exosomes for Immunoregulation and Therapeutic Intervention in Cancer
|Journal of Cancer|2016|56
Conditioned CAR-T cells by hypoxia-inducible transcription amplification (HiTA) system significantly enhances systemic safety and retains antitumor efficacy
|Journal for ImmunoTherapy of Cancer|2021|54
Identification of Dominant Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Antigen of Pandemic H1N1 Influenza Virus
|Journal of Virology|2013|41
Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors
|Frontiers in Bioengineering and Biotechnology|2022|9